United Therapeutics Corp (NAS:UTHR)
$ 556.11 +8.61 (+1.57%) Market Cap: 23.60 Bil Enterprise Value: 20.48 Bil PE Ratio: 20.53 PB Ratio: 3.97 GF Score: 88/100

United Therapeutics Corp Annual Shareholders Meeting Transcript

Jun 26, 2026 / 02:30PM GMT
Release Date Price: $542.66 (-0.13%)
Paul Mahon
United Therapeutics Corp - Executive Vice President, General Counsel, and Corporate Secretary

Welcome, everyone, to the 2026 Annual Meeting of Shareholders of United Therapeutics Corporation, which, as you can tell, is being held virtually again this year. Today is, in fact, United Therapeutics' 30th birthday, and we're kicking off our celebrations with this annual meeting.

My name is Paul Mahon, and I'm Executive Vice President, General Counsel, and Corporate Secretary of United Therapeutics. And I'm actually in the room where it happened 30 years ago today, right here where I faxed our articles of incorporation to Delaware exactly at 1 PM on June 26, 1996.

So with the history and the context aside, let's start with some introductions. Those present virtually at this meeting include Dr. Martine Rothblatt, our Chairperson and Chief Executive Officer; James Edgemond, our Chief Financial Officer and Treasurer; and John Hess, our Deputy General Counsel and Assistant Corporate Secretary. Joining us this morning are most of the members of our Board of Directors, including

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot